LG GD570 Warranty - English - Page 20

The FDA is working with the U.S. National Toxicology Program

Page 20 highlights

5. What research is needed to decide whether RF exposure from wireless phones poses a health risk? A combination of laboratory studies and epidemiological studies of people actually using wireless phones would provide some of the data that are needed. Lifetime animal exposure studies could be completed in a few years. However, very large numbers of animals would be needed to provide reliable proof of a cancer promoting effect if one exists. Epidemiological studies can provide data that is directly applicable to human populations, but ten or more years follow-up may be needed to provide answers about some health effects, such as cancer. This is because the interval between the time of exposure to a cancer-causing agent and the time tumors develop - if they do - may be many, many years. The interpretation of epidemiological studies is hampered by difficulties in measuring actual RF exposure during day-to-day use of wireless phones. Many factors affect this measurement, such as the angle at which the phone is held, or which model of phone is used. 6. What is the FDA doing to find out more about the possible health effects of wireless phone RF? The FDA is working with the U.S. National Toxicology Program and with groups of investigators around the world to ensure that high priority animal studies are conducted to address important questions about the effects of exposure to Radio Frequency (RF) energy. The FDA has been a leading participant in the World Health Organization International Electro Magnetic Fields (EMF) Project since its inception in 1996. An influential result of this work has been the development of a detailed agenda of research needs that has driven the establishment of new research programs around the world. The project has also helped develop a series of public information documents on EMF issues. The FDA and the Cellular Telecommunications & Internet Association (CTIA) have a formal Cooperative Research And Development Agreement (CRADA) to do research on wireless

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32

5. What research is needed to decide whether RF exposure
from wireless phones poses a health risk?
A combination of laboratory studies and epidemiological
studies of people actually using wireless phones would provide
some of the data that are needed. Lifetime animal exposure
studies could be completed in a few years. However, very large
numbers of animals would be needed to provide reliable proof
of a cancer promoting effect if one exists. Epidemiological
studies can provide data that is directly applicable to human
populations, but ten or more years follow-up may be needed
to provide answers about some health effects, such as cancer.
This is because the interval between the time of exposure
to a cancer-causing agent and the time tumors develop — if
they do — may be many, many years. The interpretation
of epidemiological studies is hampered by difficulties in
measuring actual RF exposure during day-to-day use of
wireless phones. Many factors affect this measurement, such
as the angle at which the phone is held, or which model of
phone is used.
6. What is the FDA doing to find out more about the possible
health effects of wireless phone RF?
The FDA is working with the U.S. National Toxicology Program
and with groups of investigators around the world to ensure
that high priority animal studies are conducted to address
important questions about the effects of exposure to Radio
Frequency (RF) energy.
The FDA has been a leading participant in the World Health
Organization International Electro Magnetic Fields (EMF)
Project since its inception in 1996. An influential result of
this work has been the development of a detailed agenda
of research needs that has driven the establishment of new
research programs around the world. The project has also
helped develop a series of public information documents on
EMF issues.
The FDA and the Cellular Telecommunications & Internet
Association (CTIA) have a formal Cooperative Research And
Development Agreement (CRADA) to do research on wireless